Persistent prurigo nodularis responsive to initiation of combination therapy with raltegravir.
作者信息
Unemori Patrick, Leslie Kieron S, Maurer Toby
出版信息
Arch Dermatol. 2010 Jun;146(6):682-3. doi: 10.1001/archdermatol.2010.128.
Abstract
摘要
相似文献
1
Persistent prurigo nodularis responsive to initiation of combination therapy with raltegravir.对开始使用雷特格韦联合治疗有反应的持久性结节性痒疹。
Arch Dermatol. 2010 Jun;146(6):682-3. doi: 10.1001/archdermatol.2010.128.
2
Persistent prurigo nodularis in HIV-infected patient responsive to antiretroviral therapy with raltegravir.接受raltegravir抗逆转录病毒治疗后反应良好的HIV感染患者的持续性结节性痒疹
J Dermatol. 2014 Mar;41(3):272-3. doi: 10.1111/1346-8138.12408. Epub 2014 Jan 31.
3
Generalized eruptive keratoacanthoma with vitiligo followed by the development of prurigo nodularis: A case report and published work review.泛发性发疹性角化棘皮瘤伴白癜风，继以痒疹结节形成：病例报告及文献复习。
J Dermatol. 2018 Feb;45(2):211-215. doi: 10.1111/1346-8138.14106. Epub 2017 Oct 23.
4
Dupilumab Treatment for Generalized Prurigo Nodularis.度普利尤单抗治疗泛发性结节性痒疹。
JAMA Dermatol. 2019 Jan 1;155(1):118-120. doi: 10.1001/jamadermatol.2018.3912.
5
Combination therapy of fexofenadine and montelukast is effective in prurigo nodularis and pemphigoid nodularis.非索非那定与孟鲁司特联合治疗结节性痒疹和结节性类天疱疮有效。
Dermatol Ther. 2014 May-Jun;27(3):135-9. doi: 10.1111/dth.12094. Epub 2013 Sep 17.
6
Prurigo nodularis and Hashimoto thyroiditis.
Ann Allergy Asthma Immunol. 2014 Dec;113(6):673-4. doi: 10.1016/j.anai.2014.09.010. Epub 2014 Oct 16.
7
Reduced Itch Associated With Dupilumab Treatment In 4 Patients With Prurigo Nodularis.度普利尤单抗治疗4例结节性痒疹患者后瘙痒减轻
JAMA Dermatol. 2019 Jan 1;155(1):121-122. doi: 10.1001/jamadermatol.2018.3906.
8
Measurement of plasma and intracellular concentrations of raltegravir in patients with HIV infection.测定 HIV 感染患者的血浆和细胞内拉替拉韦浓度。
AIDS. 2012 Nov 13;26(17):2257-9. doi: 10.1097/QAD.0b013e328359a978.
9
Darunavir-etravirine-raltegravir as salvage combination therapy in a heavily pretreated HIV-infected patient.达芦那韦-依曲韦林-雷特格韦作为挽救性联合疗法用于一名接受过大量治疗的HIV感染患者。
AIDS Patient Care STDS. 2008 Nov;22(11):841-2. doi: 10.1089/apc.2008.0051.
10
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection.在初治的HIV-1感染患者中，联合治疗96周后拉替拉韦的持续抗逆转录病毒作用。
J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):350-6. doi: 10.1097/QAI.0b013e3181b064b0.
引用本文的文献
1
Predictors of Outcomes in Prurigo Nodularis in Patients Living With HIV: A Scoping Review.HIV感染者结节性痒疹预后的预测因素：一项范围综述
J Cutan Med Surg. 2024 Nov-Dec;28(6):601-602. doi: 10.1177/12034754241274345. Epub 2024 Aug 28.
2
Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.结节性痒疹：发病机制与潜在治疗靶点。
Int J Mol Sci. 2024 May 9;25(10):5164. doi: 10.3390/ijms25105164.
3
Skin Microbiome in Prurigo Nodularis.结节性痒疹的皮肤微生物组。
Int J Mol Sci. 2023 Apr 21;24(8):7675. doi: 10.3390/ijms24087675.
4
Inflammatory dermatoses in human immunodeficiency virus.人类免疫缺陷病毒相关的炎症性皮肤病
Indian J Sex Transm Dis AIDS. 2017 Jul-Dec;38(2):113-120. doi: 10.4103/ijstd.IJSTD_22_17.
本文引用的文献
1
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.基于拉替拉韦与基于依非韦伦的联合疗法在初治HIV-1感染患者中的安全性和有效性：一项多中心、双盲随机对照试验。
Lancet. 2009 Sep 5;374(9692):796-806. doi: 10.1016/S0140-6736(09)60918-1. Epub 2009 Aug 3.
2
Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase.使用整合酶抑制剂拉替拉韦进行抗逆转录病毒治疗会改变HIV的衰减动力学，显著缩短第二阶段。
AIDS. 2007 Nov 12;21(17):2315-21. doi: 10.1097/QAD.0b013e3282f12377.
3
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.作为初治HIV-1感染患者联合治疗一部分的HIV-1整合酶抑制剂raltegravir的快速持久抗逆转录病毒作用：一项48周对照研究的结果
J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):125-33. doi: 10.1097/QAI.0b013e318157131c.
4
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.HIV-1整合酶抑制剂拉替拉韦（MK-0518）在接受过多种药物治疗的耐多药病毒患者中的安全性和疗效：一项II期随机对照试验。
Lancet. 2007 Apr 14;369(9569):1261-1269. doi: 10.1016/S0140-6736(07)60597-2.
5
Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience.高效抗逆转录病毒治疗时代的HIV皮肤表现：一家城市机构诊所的经验
J Am Acad Dermatol. 2006 Apr;54(4):581-8. doi: 10.1016/j.jaad.2005.12.030. Epub 2006 Feb 23.
6
Prurigo nodularis: a review.结节性痒疹：综述
Australas J Dermatol. 2005 Nov;46(4):211-18; quiz 219-20. doi: 10.1111/j.1440-0960.2005.00187.x.
7
Helicobacter pylori and prurigo nodularis.幽门螺杆菌与结节性痒疹。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2269-72.
8
Histopathological and bacteriological findings in prurigo nodularis.结节性痒疹的组织病理学和细菌学 findings。
需注意，这里“findings”直接保留英文未翻译，因为它在医学语境中有特定含义，常不做翻译，直接表述为“结果、发现”等意思，如果按照完整准确的翻译可以是“结节性痒疹的组织病理学和细菌学检查结果” 。
Acta Derm Venereol. 1997 Jan;77(1):49-51. doi: 10.2340/0001555577049051.
Zotero 插件